ESR1 and breast cancer: In the MDA-MB-231 cell line, an ER (estrogen receptor)-negative cell line, EZH2 positively activated the transcription of NF-κB target genes in a methyltransferase-independent way, which contributed to aggressiveness of these breast cancer cells.